Can an herbal ointment heal bedsores faster? a large Real-World study investigates
NCT ID NCT07761078
First seen Aug 12, 2026 · Last updated Aug 13, 2026 · Updated 1 time
Summary
This study looks at whether Jingwanhong Ointment, a traditional Chinese medicine applied to the skin, can safely and effectively treat pressure injuries (bedsores) in people who are bedridden long-term. Researchers will follow about 500 participants to measure how quickly wounds heal, the complete healing rate, and pain levels. They will also explore if people with different traditional Chinese medicine patterns respond differently to the treatment.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Jingwanhong Ointment, a topical compound traditional Chinese medicine ointment applied to the wound to promote healing.
- What this could lead to
- If effective, this could offer a safe, accessible treatment option to speed up bedsore healing and reduce pain in bedridden patients.
- What could go wrong
- This is an observational study, not a controlled trial, so results may be influenced by other factors. The ointment's effectiveness and safety in real-world use are still being confirmed.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 500 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Aug 2026
An estimate. Start dates often move.
- Expected to finish
-
Feb 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
This study will enroll long-term bedridden patients aged over 18 years with an expected survival of at least 3 months and an anticipated bed rest duration exceeding 1 month. Eligible participants must have a clinically diagnosed pressure injury (Stage I-IV), based on the diagnostic and staging criteria from the NPUAP/EPUAP/PPPIA Prevention and Treatment of Pressure Ulcers/Injuries: Clinical Practice Guideline (2019). Patients will additionally be classified by traditional Chinese medicine (TCM) syndrome type-Qi Stagnation and Blood Stasis, Toxin Accumulation with Putrefaction, or Qi-Blood Deficiency-according to the 2019 guideline issued by the China Association of Chinese Medicine. All participants must voluntarily agree to join the study and provide signed informed consent. Patients will be excluded if they have a known allergy or hypersensitivity to any component of Jingwanhong Ointment, have a diagnosed psychiatric disorder, present with a wound showing malignant transformation or
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age \> 18 years * Expected survival ≥ 3 months * Long-term bedridden patients with an anticipated bed rest duration exceeding 1 month. * Clinically diagnosed with pressure injury (Stage I-IV), based on the diagnostic and staging criteria defined in the Prevention and Treatment of Pressure Ulcers/Injuries: Clinical Practice Guideline (2019), jointly developed by the National Pressure Ulcer Advisory Panel (NPUAP), the European Pressure Ulcer Advisory Panel (EPUAP), and the Pan Pacific Pressure Injury Alliance (PPPIA). TCM syndrome differentiation will be based on the Clinical Diagnosis and Treatment Guideline for Bedsores in Traditional Chinese Medicine Surgery, issued by the China Association of Chinese Medicine in January 2019, classifying patients into three syndrome types: Qi Stagnation and Blood Stasis, Toxin Accumulation with Putrefaction, and Qi-Blood Deficiency * Willing to participate in the study and provide signed informed consent Exclusion Criteria: * Known allergy or hypersensitivity to any component of Jingwanhong Ointment * Diagnosed with a psychiatric disorder * Wound with malignant transformation or fistula formation * Currently participating in another clinical trial
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Bedsores are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.